Cogent Biosciences, Inc. COGT Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s increase (decrease) in other operating assets?
- Cogent Biosciences, Inc. (COGT) reported increase (decrease) in other operating assets of -$1.36M in Q1 2026.
- What does increase (decrease) in other operating assets mean?
- This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.